POC5 Antikörper (AA 301-400)
-
- Target Alle POC5 Antikörper anzeigen
- POC5 (POC5 Centriolar Protein Homolog (POC5))
-
Bindungsspezifität
- AA 301-400
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser POC5 Antikörper ist unkonjugiert
- Applikation
- ELISA, Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Kreuzreaktivität
- Human
- Homologie
- Mouse,Rat,Dog,Cow,Sheep,Pig,Horse,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human POC5
- Isotyp
- IgG
- Top Product
- Discover our top product POC5 Primärantikörper
-
-
- Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- POC5 (POC5 Centriolar Protein Homolog (POC5))
- Andere Bezeichnung
- POC5 (POC5 Produkte)
- Synonyme
- C5orf37 antikoerper, RGD1310597 antikoerper, 1200014M14Rik antikoerper, AV144706 antikoerper, POC5 centriolar protein antikoerper, POC5 antikoerper, Poc5 antikoerper
- Hintergrund
-
Synonyms: C5orf37, Centrosomal protein POC5, FLJ35779, hPOC5, Poc5, POC5 centriolar protein homolog Chlamydomonas, POC5_HUMAN, Protein of centriole 5, Proteome of centriole 5.
Background: Essential for the assembly of the distal half of centrioles, required for centriole elongation.
-